Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, and Lung Cancer Treatments and Mutations.
Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases.
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma
Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort study.
Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.
Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer
Identification of lymphophilic subtype in resectable esophageal squamous cell carcinoma using genetic signatures from large-scale genomic repertoires
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade.
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma.
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy
Expert consensus on resection of chest wall tumors and chest wall reconstruction
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.
Lymph node dissection and recurrent laryngeal nerve protection in minimally invasive esophagectomy
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel